Journey Medical Corporation
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
56.52 |
70.71 |
109.63 |
161.84 |
211.69 |
237.16 |
Przychód Δ r/r |
0.00% |
25.10% |
55.04% |
47.63% |
30.80% |
12.03% |
Przychód (min) |
55.90 |
68.06 |
91.18 |
161.84 |
187.49 |
210.05 |
Przychód (max) |
57.14 |
73.36 |
127.77 |
161.85 |
234.29 |
262.48 |
EBITDA (średnia) |
-8.46 |
-10.59 |
-16.41 |
-24.23 |
-31.70 |
-35.51 |
EBIT (średnia) |
-11.23 |
-14.05 |
-21.79 |
-32.17 |
-42.07 |
-47.14 |
EBIT % |
-19.88% |
-19.88% |
-19.88% |
-19.88% |
-19.88% |
-19.88% |
Zysk netto (średni) |
-20.43 |
-3.98 |
21.87 |
50.26 |
70.69 |
63.13 |
Zysk netto % |
-36.15% |
-5.63% |
19.95% |
31.05% |
33.39% |
26.62% |
EPS (średnia) |
-1.00 |
-0.20 |
0.91 |
2.19 |
3.46 |
3.09 |
Liczba analityków (Przychody) |
3 |
3 |
4 |
2 |
1 |
1 |
Liczba analityków (EPS) |
3 |
3 |
4 |
2 |
1 |
1 |
symbol |
DERM |
DERM |
DERM |
DERM |
DERM |
DERM |